Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. (Q48200427)

9 February 2018

title

Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. (English)

1 reference

9 February 2018

1 reference

1 reference

5

1 reference

9 February 2018

author name string

Tchougounova E

1

1 reference

9 February 2018

Kastemar M

2

1 reference

9 February 2018

Bråsäter D

3

1 reference

9 February 2018

Holland EC

4

1 reference

9 February 2018

Uhrbom L

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

16 April 2007

1 reference

9 February 2018

published in

Oncogene

1 reference

9 February 2018

volume

26

1 reference

9 February 2018

page(s)

6289-6296

1 reference

9 February 2018

issue

43

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210455

exact match

0 references

cites work

Epidermal growth factor receptor and Ink4a/Arf

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Platelet-derived growth factor and its receptor expression in human oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Staurosporine is a potent activator of neuronal, glial, and "CNS stem cell-like" neurosphere differentiation in murine embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Role of the INK4a locus in tumor suppression and cell mortality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210455

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210455

1 reference

9 February 2018

PubMed ID

17438529

1 reference

9 February 2018